Approval · Notice of Compliance 21424 · 2018
SENSORCAINE: Notice of Compliance 21424
Issued October 16, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21424
- Date
- October 16, 2018
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | Not yet assigned | — |
| SENSORCAINE WITH EPINEPHRINE | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- EPINEPHRINE 0.01 MG per ML